{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-079855","form_type":"8-K","ticker":null,"cik":"0000727207","company_name":"Accelerate Diagnostics, Inc","filed_at":"2025-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.242433+00:00","generated_at":"2026-05-17T12:12:44.997958+00:00","sec_items":["1.01","1.03","2.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Accelerate Diagnostics closes asset sale; Chapter 11 liquidation plan confirmed, equity canceled","bullets":["On August 8, 2025, closed sale of certain assets to Indaba Starling (affiliate of Indaba Capital) under amended asset purchase agreement.","On August 13, 2025, Bankruptcy Court confirmed Second Amended Combined Disclosure Statement and Chapter 11 Plan of Liquidation.","Plan effective date expected on or about August 18, 2025; all common stock and warrants canceled, holders receive no distribution.","As of confirmation, company had approximately 25,477,516 shares outstanding with no shares reserved for future issuance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-079855","json":"https://secwatch.observer/filing/0001104659-25-079855.json","markdown":"https://secwatch.observer/filing/0001104659-25-079855.md","text":"https://secwatch.observer/filing/0001104659-25-079855.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/727207/000110465925079855/0001104659-25-079855-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/727207/000110465925079855/tm2523695d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:12:44.997958+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9faab2019b524fa78fa7688ba4715e04a8683446","claim":"Accelerate Diagnostics, Inc entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2025-05-08).","evidence_excerpt":"As previously disclosed, on May 8, 2025, Accelerate Diagnostics, Inc., a Delaware corporation (the “ Company ”), and its US subsidiary, Accelerate Diagnostics Texas, LLC (collectively, with the Company, the “ Company Parties ”), filed voluntary petitions for relief (the “ Bankruptcy Petitions ”) under Chapter 11 of the United States Code (the “ Bankruptcy Code ”) in the United States Bankruptcy Court for the District of Delaware (such court, the “ Court ” and such cases, the “ Cases ”).","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/727207/000110465925079855/0001104659-25-079855-index.htm","confidence":0.99,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 11"},{"label":"Court","value":"United States Bankruptcy Court for the District of Delaware"},{"label":"Petition","value":"2025-05-08"}],"fact_type":"distress_event"},{"claim_id":"70b1062d5af720ed206d9f803fbda5db0c984b9c","claim":"Accelerate Diagnostics, Inc completed a disposition involving an affiliate of Indaba Capital Management, L.P. (closed 2025-08-08).","evidence_excerpt":"On August 8, 2025, the Company and Buyer consummated the Sale Transaction.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/727207/000110465925079855/0001104659-25-079855-index.htm","confidence":0.7,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"an affiliate of Indaba Capital Management, L.P."},{"label":"Closing","value":"2025-08-08"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}